Corcept Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:CORT

Comments

Corcept Therapeutics Inc Earnings Estimates

CORTNASDAQ

Trade with Public

$46.16

2.205.00%

At close: Apr 17, 5:00 PM EST

$46.56

0.400.87%

After Hours: 7:30 PM EST

Overview NewsEarningsOptions Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Corcept Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:CORT

Corcept Therapeutics (CORT) is scheduled to report Q1 earnings on May 4, 2026. Analysts estimate EPS of $-0.21 and quarterly revenue of $180.94M.

In the most recent quarter (Q4), Corcept Therapeutics reported EPS of $0.20, missing estimates of $0.31 by 0.35%. Revenue came in at $202.13M, missing the estimate of $254.72M by 0.21%.

Over the last 4 quarters, Corcept Therapeutics has averaged an EPS surprise of 0.27% and a revenue surprise of 0.10%.

Earnings Date

May 4

EPS Estimate

$-0.210

Quarterly Revenue Estimate

$180.94M

Annual Revenue
(as of Dec 31)

$761.41M

Corcept Therapeutics Earnings History

Analyze the earnings history of Corcept Therapeutics using advanced sorting and filters.

Loading calendar...

Corcept Therapeutics (CORT) Earnings Per Share

The chart below shows Corcept Therapeutics's reported EPS compared to analyst estimates over recent quarters.

Corcept Therapeutics (CORT) Revenue

The chart below shows Corcept Therapeutics's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Corcept Therapeutics (NASDAQ:CORT) reporting earnings?

Corcept Therapeutics (CORT) is scheduled to report earnings on May 4, 2026. The last reported earnings were for reported on February 24, 2026 for Q4.

What were the latest earnings per share (EPS) for Corcept Therapeutics (NASDAQ:CORT)?

The Actual EPS was $0.20, which missed the estimate of $0.31.

What were Corcept Therapeutics’s (NASDAQ:CORT) revenues?

The Actual Revenue was $202.13M, which missed the estimate of $254.72M.

People Also Watch

Terns Pharmaceuticals Inc

Axsome Therapeutics Inc

NASDAQ:AXSM

$189.02

0.02%

Corcept Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:CORT

Corcept Therapeutics (CORT) is scheduled to report Q1 earnings on May 4, 2026. Analysts estimate EPS of $-0.21 and quarterly revenue of $180.94M.

In the most recent quarter (Q4), Corcept Therapeutics reported EPS of $0.20, missing estimates of $0.31 by 0.35%. Revenue came in at $202.13M, missing the estimate of $254.72M by 0.21%.

Over the last 4 quarters, Corcept Therapeutics has averaged an EPS surprise of 0.27% and a revenue surprise of 0.10%.

Earnings Date

May 4

EPS Estimate

$-0.210

Quarterly Revenue Estimate

$180.94M

Annual Revenue
(as of Dec 31)

$761.41M